Cargando…
Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study
AIM: To identify significant liver disease [including nodular regenerative hyperplasia (NRH)] in asymptomatic Didanosine (DDI) exposed human immunodeficiency virus (HIV) positive patients. METHODS: Patients without known liver disease and with > 6 mo previous DDI use had liver stiffness assessed...
Autores principales: | Logan, Sarah, Rodger, Alison, Maynard-Smith, Laura, O’Beirne, James, Fernandez, Thomas, Ferro, Filippo, Smith, Colette, Bhagani, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192554/ https://www.ncbi.nlm.nih.gov/pubmed/28083085 http://dx.doi.org/10.4254/wjh.v8.i36.1623 |
Ejemplares similares
-
Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers
por: Lombardi, Rosa, et al.
Publicado: (2017) -
Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency
por: Høgh, Julie, et al.
Publicado: (2022) -
Bioretrosynthetic construction of a didanosine biosynthetic pathway
por: Birmingham, William R., et al.
Publicado: (2014) -
Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
por: Janneh, Omar, et al.
Publicado: (2011) -
Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC
por: Severino, Patrícia, et al.
Publicado: (2012)